Literature DB >> 17659733

Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type.

Nebil Bal1, Sedat Yildirim, Tarik-Z Nursal, Filiz Bolat, Fazilet Kayaselcuk.   

Abstract

AIM: To investigate the correlation between ezrin expression and types of gastric carcinoma and clinico-pathological variables.
METHODS: We examined ezrin protein expression in 75 gastric carcinoma (53 intestinal types of adenocarcinoma, 22 diffuse types of carcinoma) tissues by immunohistochemistry. The results were compared with clinicopathological parameters such as tumor type, grade of tumor, clinical stage, presence of metastatic lymph node, and depth of invasion.
RESULTS: Ezrin immunostaining was positive in 43 cases (81.1%) of intestinal type and in 9 (40.9%) cases of diffuse type adenocarcinomas (P < 0.001). In gastric carcinomas, the expression of ezrin protein correlated with the status of H pylori and survival. There was no correlation between expression of ezrin with TNM stage and histological grade of gastric carcinomas (P > 0.05).
CONCLUSION: The low expression of ezrin implicates the loss of adhesion in diffuse carcinomas. Furthermore, overexpression of ezrin in carcinomas with H pylori infection may be a genuine specific pathway in which H pylori may cause/initiate gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17659733      PMCID: PMC4250645          DOI: 10.3748/wjg.v13.i27.3726

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  18 in total

1.  Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma.

Authors:  Kaori Ohtani; Hideki Sakamoto; Thomas Rutherford; Zhaocong Chen; Atushi Kikuchi; Tatsuo Yamamoto; Kazuo Satoh; Frederick Naftolin
Journal:  Cancer Lett       Date:  2002-05-08       Impact factor: 8.679

Review 2.  Molecular-pathological diagnosis of gastrointestinal tissues and its contribution to cancer histopathology.

Authors:  W Yasui; H Yokozaki; F Shimamoto; H Tahara; E Tahara
Journal:  Pathol Int       Date:  1999-09       Impact factor: 2.534

3.  Ezrin, a membrane-cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells.

Authors:  K Ohtani; H Sakamoto; T Rutherford; Z Chen; K Satoh; F Naftolin
Journal:  Cancer Lett       Date:  1999-12-01       Impact factor: 8.679

4.  Essential functions of ezrin in maintenance of cell shape and lamellipodial extension in normal and transformed fibroblasts.

Authors:  R F Lamb; B W Ozanne; C Roy; L McGarry; C Stipp; P Mangeat; D G Jay
Journal:  Curr Biol       Date:  1997-09-01       Impact factor: 10.834

Review 5.  The role of the CD44/ezrin complex in cancer metastasis.

Authors:  Tracey A Martin; Gregory Harrison; Robert E Mansel; Wen G Jiang
Journal:  Crit Rev Oncol Hematol       Date:  2003-05       Impact factor: 6.312

6.  Cellular stress-related protein expression in Helicobacter pylori-infected gastric epithelial AGS cells.

Authors:  Joo Weon Lim; Hyeyoung Kim; Jung Mogg Kim; Joo Sung Kim; Hyun Chae Jung; Kyung Hwan Kim
Journal:  Int J Biochem Cell Biol       Date:  2004-08       Impact factor: 5.085

7.  Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients.

Authors:  Jarna Moilanen; Heini Lassus; Arto Leminen; Antti Vaheri; Ralf Bützow; Olli Carpén
Journal:  Gynecol Oncol       Date:  2003-08       Impact factor: 5.482

8.  Ezrin regulates E-cadherin-dependent adherens junction assembly through Rac1 activation.

Authors:  Philippe Pujuguet; Laurence Del Maestro; Alexis Gautreau; Daniel Louvard; Monique Arpin
Journal:  Mol Biol Cell       Date:  2003-02-06       Impact factor: 4.138

9.  Perturbation of cell adhesion and microvilli formation by antisense oligonucleotides to ERM family members.

Authors:  K Takeuchi; N Sato; H Kasahara; N Funayama; A Nagafuchi; S Yonemura; S Tsukita; S Tsukita
Journal:  J Cell Biol       Date:  1994-06       Impact factor: 10.539

10.  Ezrin regulates cell-cell and cell-matrix adhesion, a possible role with E-cadherin/beta-catenin.

Authors:  S Hiscox; W G Jiang
Journal:  J Cell Sci       Date:  1999-09       Impact factor: 5.285

View more
  8 in total

1.  Expression of ezrin in human embryonic, fetal, and normal adult tissues.

Authors:  Jian-Jun Xie; Fa-Ren Zhang; Li-Hua Tao; Zhuo Lü; Xiu-E Xu; Li-Yan Xu; En-Min Li
Journal:  J Histochem Cytochem       Date:  2011-08-10       Impact factor: 2.479

2.  Ezrin is associated with gastric cancer progression and prognosis.

Authors:  Li Li; Yuan-Yu Wang; Zhong-Sheng Zhao; Jie Ma
Journal:  Pathol Oncol Res       Date:  2011-06-30       Impact factor: 3.201

3.  The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors.

Authors:  Bulent Cetin; Ipek Isık Gonul; Suleyman Buyukberber; Barıs Afsar; Ozge Gumusay; Efnan Algın; Nedim Turan; Ahmet Ozet; Mustafa Benekli; Ugur Coskun
Journal:  Tumour Biol       Date:  2015-05-31

4.  Ezrin expression as a prognostic marker in colorectal adenocarcinoma.

Authors:  Marcelo Patara; Erika Maria Monteiro Santos; Renata de Almeida Coudry; Fernando Augusto Soares; Fábio Oliveira Ferreira; Benedito Mauro Rossi
Journal:  Pathol Oncol Res       Date:  2011-04-05       Impact factor: 3.201

5.  Ezrin expression and its phosphorylation in gastric carcinoma with lymphoid stroma and Epstein-Barr virus infection.

Authors:  Taro Tobo; Minako Hirahashi; Takashi Yao; Shinichi Aishima; Yoshinao Oda
Journal:  Mol Clin Oncol       Date:  2012-12-28

6.  Association of Ezrin expression with the progression and prognosis of gastrointestinal cancer: a meta-analysis.

Authors:  Feng Liang; Yangxin Wang; Ligen Shi; Jianmin Zhang
Journal:  Oncotarget       Date:  2017-10-04

7.  Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma.

Authors:  Jingchun Jin; Tiefeng Jin; Meiling Quan; Yingshi Piao; Zhenhua Lin
Journal:  Diagn Pathol       Date:  2012-10-05       Impact factor: 2.644

Review 8.  Pathophysiological Roles of Actin-Binding Scaffold Protein, Ezrin.

Authors:  Kotoku Kawaguchi; Shinji Asano
Journal:  Int J Mol Sci       Date:  2022-03-17       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.